Future Aspects in Contraception Proceeding of an International Symposium held in Heidelberg, 5–8 September 1984 Part 1 Male Contraception
Atrophy of gonadotrophin producing cells Exogenously LH synthesis administered androgens and release or anabolic steroids are decreased Prostate Testes Normal function. Testosterone synthesis in The deficit of endogenously Leydig cells is decreased. The synthesized testosterone is exogenously admini...
| Main Authors: | , , |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Dordrecht
Springer Netherlands
1985, 1985
|
| Edition: | 1st ed. 1985 |
| Subjects: | |
| Online Access: | |
| Collection: | Springer Book Archives -2004 - Collection details see MPG.ReNa |
Table of Contents:
- of Part 1
- 1 Future aspects in contraception: An overview
- 2 Steroidal contraception—Experimental background
- 3 Male contraception in the preclinical evaluation
- 4 Long-acting steroids for male contraception
- 5 Relationship between ligand structure and affinity for androgen binding protein
- 6 Male contraception with LHRH agonists
- 7 The epididymis as a target for contraception: Role of testosterone metabolism
- 8 Effect of 6-month treatment with a gonadotropin releasing hormone agonist analogue on endocrine and histological features of human testis tissue
- 9 The future of plant-derived chemicals as contraceptive agents
- 10 Gossypol—the male fertility-regulating agent
- 11 Cottonseed oil for birth control
- 12 Antifertility activity of (—)-gossypol
- 13 Monoclonal antibodies directed against human sperm antigens
- 14 Influence of psychotropic drugs, gossypol and acetylcholine receptor blockers on the motility of human spermatozoa in vitro
- 15 Investigations on the spermicidal action of cellulose trisulphuric acid ester
- Index of contraceptive agents